| Literature DB >> 33923803 |
Ioanna Mylona1, Vassilis Aletras2, Nikolaos Ziakas1, Ioannis Tsinopoulos1.
Abstract
The Visual Functioning-14 (VF-14) scale is the most widely employed index of vision-related functional impairment and serves as a patient-reported outcome measure in vision-specific quality of life. The purpose of this study is to rigorously examine and validate the VF-14 scale on a Greek population of ophthalmic patients employing Rasch measurement techniques. Two cohorts of patients were sampled in two waves. The first cohort included 150 cataract patients and the second 150 patients with other ophthalmic diseases. The patients were sampled first while pending surgical or other corrective therapy and two months after receiving therapy. The original 14-item VF-14 demonstrated poor measurement precision and disordered response category thresholds. A revised eight-item version, the VF-8G ('G' for 'Greek'), was tested and confirmed for validity in the cataract research population. No differential functioning was reported for gender, age, and underlying disorder. Improvement in the revised scale correlated with improvement in the mental and physical component of the general health scale SF-36. In conclusion, our findings support the use of the revised form of the VF-14 for assessment of vision-specific functioning and quality of life improvement in populations with cataracts and other visual diseases than cataracts, a result that has not been statistically confirmed previously.Entities:
Keywords: HRQOL; PROM; Rasch modeling; VF-14; visual functioning
Mesh:
Year: 2021 PMID: 33923803 PMCID: PMC8072548 DOI: 10.3390/ijerph18084254
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Underlying disorders.
| Disorder | N | Percent | Age in Years (Mean/SD) | Males (N/%) | Females |
|---|---|---|---|---|---|
| Cataract | 150 | 50 | 73.67 (7.93) | 86 (57.3%) | 64 (42.7%) |
| Age-related macular degeneration | 30 | 10 | 74.13 (6.23) | 18 (60%) | 12 (40%) |
| Glaucoma | 24 | 8 | 69.04 (8.47) | 13 (54.2%) | 11 (45.8%) |
| Ectropion | 18 | 6 | 71 (7.5) | 15 (83.3%) | 3 (16.7%) |
| Proliferative diabetic retinopathy | 16 | 5.3 | 67.56 (10.16) | 11 (68.8%) | 3 (31.3%) |
| Canalicular obstruction | 13 | 4.3 | 73.46 (6.1) | 5 (38.5%) | 8 (61.5%) |
| Blepharitis | 13 | 4.3 | 74.92 (5.34) | 7 (53.8%) | 6 (46.2%) |
| Central vein occlusion | 10 | 3.3 | 72.8 (4.1) | 3 (30%) | 7 (70%) |
| Dry eye | 10 | 3.3 | 72.6 (6.77) | 8 (80%) | 2 (20%) |
| Retinal vein occlusion | 5 | 1.7 | 69 (4.06) | 2 (40%) | 3 (60%) |
| Ptosis | 5 | 1.7 | 71.6 (4.56) | 3 (60%) | 2 (40%) |
| Keratoconus | 4 | 1.3 | 61.5 (2.88) | 4 (100%) | |
| Fuchs’s endothelial dystrophy | 2 | 0.7 | 51 (2.82) | 2 (100%) | |
| Total | 300 | 100 |
Fit statistics for the modified VF-14 items.
| Original VF-14 Item | MODEL | INFIT | OUTFIT | EXACT MATCH | ||||
|---|---|---|---|---|---|---|---|---|
| Measure | S.E. | MNSQ | ZSTD | MNSQ | ZSTD | Observed% | Expected% | |
| VF6 | 0.33 | 0.09 | 1.51 | 5.50 | 1.51 | 5.29 | 53.7 | 58.9 |
| VF4 | −1.86 | 0.10 | 1.26 | 3.00 | 1.28 | 2.79 | 53.7 | 62.3 |
| VF1 | 1.72 | 0.09 | 1.03 | 0.37 | 1.02 | 0.20 | 52.7 | 57.9 |
| VF12 | −0.80 | 0.10 | 0.94 | −0.74 | 0.95 | −0.55 | 63.4 | 60.3 |
| VF3 | −0.58 | 0.10 | 0.87 | −1.65 | 0.86 | −1.75 | 69.8 | 59.7 |
| VF8 | 0.11 | 0.10 | 0.82 | −2.34 | 0.82 | −2.22 | 63.4 | 59.2 |
| VF7 | 0.43 | 0.09 | 0.80 | −2.60 | 0.78 | −2.87 | 64.1 | 58.4 |
| VF2 | 0.66 | 0.09 | 0.74 | −3.57 | 0.74 | −3.38 | 61.4 | 58.1 |
| Mean | 0.00 | 0.10 | 1.00 | −0.3 | 0.99 | −0.3 | 60.3 | 59.3 |
| P.SD | 1.01 | 0.00 | 0.25 | 2.9 | 0.25 | 2.8 | 5.8 | 1.3 |
S.E. = Standard Error, MSNQ = Mean Square, ZSTD = Z–standardized, P.SD = Population Standard Deviation.
Figure 1Category probability curves for the VF-14 (left) and the VF-8G scales, demonstrating the operation of the five-item Likert-style response categories. The VF-14 has clearly disordered thresholds with the second response lacking any range along with the ability score where it is most likely to be chosen over the other responses.
Differential Item Functioning (DIF) by Gender, age, and disorder.
| Original VF-14 Item | DIF by Gender | DIF by Age | DIF by Disorder | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Contrast | Welch’s Test | ≤70 Years | >70 Years | Contrast | Welch’s Test | Cataract | Other | Contrast | Welch’s Test | |
| VF1 | 1.89 | 1.47 | 0.42 | 0.027 | 1.82 | 1.67 | 0.15 | 0.462 | 1.85 | 1.59 | 0.26 | 0.174 |
| VF2 | 0.66 | 0.66 | 0.00 | 1.000 | 0.97 | 0.50 | 0.46 | 0.02 | 0.66 | 0.66 | 0.00 | 1.000 |
| VF3 | −0.52 | −0.68 | 0.17 | 0.397 | −0.54 | −0.61 | 0.07 | 0.736 | −0.58 | −0.58 | 0.00 | 1.000 |
| VF4 | −1.91 | −1.79 | −0.12 | 0.565 | −2.09 | −1.75 | −0.33 | 0.131 | −1.86 | −1.86 | 0.00 | 1.000 |
| VF6 | 0.18 | 0.54 | −0.36 | 0.06 | 0.42 | 0.29 | 0.13 | 0.513 | 0.48 | 0.17 | 0.31 | 0.102 |
| VF7 | 0.47 | 0.37 | 0.10 | 0.6 | 0.39 | 0.43 | −0.04 | 0.848 | 0.47 | 0.39 | 0.07 | 0.692 |
| VF8 | 0.04 | 0.20 | −0.16 | 0.41 | −0.04 | 0.18 | −0.22 | 0.284 | −0.01 | 0.23 | −0.24 | 0.207 |
| VF12 | −0.83 | −0.77 | −0.05 | 0.787 | −1.00 | −0.71 | −0.29 | 0.162 | −1.00 | −0.60 | −0.40 | 0.041 |
DIF = Differential Item Functioning.
Figure 2(a). Wright map for the VF-14 scale. Items on the scale are marked VF1-VF17, M = mean difficulty of the items, S = one standard deviation, T = two standard deviations; (b). Wright map for the VF-8G scale. Items on the scale are marked VF1-VF12, M = mean difficulty of the items, S = one standard deviation, T = two standard deviations.
Rasch-based metric properties of the English and Greek VF-14 scales and the short versions proposed by Gothwal et al. [5] and this study (VF-8G).
| Parameter | English Version | Greek Version | ||
|---|---|---|---|---|
| VF-14 | VF-8R | VF-14 | VF-8G | |
| Number of items | 14 | 8 | 14 | 8 |
| Measurement precision | 2.45 | 2.29 | 2.06 | 2.85 |
| Mis-fitting items | 2 | 0 | 6 | 0 |
| Mean person location | −1.86 | −1.97 | −0.44 | 0.68 |
| PCA, eigenvalue first contrast | 2.3 | 1.6 | 2.46 | 1.99 |
Results from the application of the VF-8G scale in the research sample.
| Estimated Person Measure (Mean/S.D) | Gender | Total | ||
|---|---|---|---|---|
| Male | Female | |||
| Disease Group | Cataract | 0.464 (2.12) | 0.05 (1.77) | 0.29 (1.98) |
| Other | 0.921 (1.95) | 1.274 (2.27) | 1.06 (2.08) | |
| All | 0.696 (2.04) | 0.65 (2.11) | ||
Figure 3(a). Bland-Altman plot of agreement between the Gothwal et al. [5] 8-item VF-8R and the Greek version VF-8G pre-operatively. (b). Bland-Altman plot of agreement between the Gothwal et al. [5] 8-item VF-8R and the Greek version VF-8G post-operatively.